The highest-ranked abstracts will be selected for presentation. There will be six concurrent sessions broken up by abstract topic. Check back soon for more session information.
Read more...The placebo effect is a known aspect in the practice of medicine. In the clinical setting, it has been relegated to statistical confounds. In this session, we will discuss ways to identify and predict the placebo effect as well as brain connectivity that leads to placebo.
Read more...As hospitals and physician reimbursement becomes increasingly tied to outcomes, how we manage patients at greater risk of complications becomes paramount. In this session, we discuss risk mitigation strategies and the role of surgical policies to limit infection and revision rate.
Read more...Deep brain stimulation is well established for the treatment of movement disorders. Its use in OCD is becoming more common. Work is on-going in fields- new and old. This session serves as an update to the progress in those indications.
Read more...The first year out in practice is a milestone year for the early career physician. This session will begin with a framework for accelerating the newly-minted attending's professional and reputational development and conclude with a practical real-world guide to opioid management in 2020.
Read more...This session will highlight recent advances in understanding for chronic pain management that influence procedural outcomes. The session will define the influence of opioids on surgical outcomes and methods to mitigate the negative effects. Contrast hypersensitivity reactions will be explored and best practices will be defined. Recent concerns regarding gadolinium-based contrast agents including brain deposition and acute neurotoxicity will be characterized. Furthermore, the significant concerns surrounding gadolinium use as an alternative contrast agent in individuals with iodinated contrast hypersensitivity reactions will be explored. The future of interventional headache care will be explored. The session will also analyze the current research on analgesic pharmacological and interventional therapies and their impact on cancer disease progression and recurrence.
Read more...This session will examine the scope of medical consulting and potential for conflict of interest (COI). We will examine how COI is managed in the sphere of Neuromodulation compared to other sectors of organized medicine. We will discuss the implications of COI for physicians as individuals and collectively.
Read more...This session will present several forms of non-invasive techniques for modulating activity in the nervous system. These techniques will include electrical, magnetic, and optical stimulation modalities. This session will address the feasibility of these approaches in clinical applications and present future directions. This session will cover non-invasive modulation of activity in the vagus nerve and the brain.
Read more...Faculty subject to change.